Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreAccelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreYour world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks--GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.
Learn MoreFor government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.
Learn MoreA curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREGet the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!
LEARN MOREThought leaders are vital to an effective product market strategy, but identifying and engaging those experts can be a difficult process that yields inadequate results. Today's healthcare providers need to look beyond traditional key opinion leaders and turn to network science to support effective thought leader targeting for the most successful launch and commercialization outcomes.
Thought leaders exist at national, regional, and local levels, playing different roles in advancing product adoption through their network of healthcare provider (HCP) relationships. HCPs rely on trusted thought leaders for new learning and to support their decisions to try new therapies. Understanding which thought leaders are creating awareness and adoption within their HCP networks will help you target the most effective messaging and engagements toward the most impactful HCPs at the right time. IQVIA Peer Learning Insights combines primary research with artificial intelligence / predictive analytics providing the industry with critical network data that has until now been impossible to see.
Building a comprehensive understanding of disease-specific leadership requires a combination of methodologies. Your product’s point in the lifecycle helps us customize the selection of identification methodologies. Network science allows for effective leader targeting at ALL levels in the market, accelerating network adoption of new science and products. Adoption can be accelerated through an understanding of the network relationships between thought leaders and their HCP peers.
HCPs rely on their trusted thought leaders now more than ever as a critical educational source for medical information. Your success hinges on
IQVIA’s approach to Thought Leadership Network (TLN) identification results in precise targeting utilizing proprietary scoring, tiering, and segmentation to match the “right” thought leaders to their naturally occurring networks, and deliver the optimal engagement opportunities to achieve your desired outcomes.
Our approach provides insight into thought leadership, as well as the HCP networks that these leaders impact and shape behaviorally. The results are provided in an integrated online database that can be extended to provide a platform for proactive Thought Leader engagement planning. Comprehensive identification uses a wide range of methodologies to identify, profile, and segment leaders that are aligned to the brand strategy and medical message platforms.
